SCHEMBL9854328

SCHEMBL9854328

CN(c1ccc(-c2ccccc2C#N)cc1)c1ncccc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
CYP1A2 P05177 3/20 0.44
CYP3A4 P08684 3/20 0.44
HSD17B10 Q99714 3/20 0.44
HPGD P15428 1/20 0.44
ESR2 Q92731 1/20 0.42
HDAC1 Q13547 1/20 0.38
ALOX5AP P20292 2/20 0.38
FEN1 P39748 2/20 0.38
AGTR1 P30556 1/20 0.37
AGTR2 P50052 1/20 0.37
CYP11B2 P19099 1/20 0.37
HTT P42858 1/20 0.37
IKBKB O14920 1/20 0.37
MAPK1 P28482 2/20 0.36
CLK4 Q9HAZ1 2/20 0.36
AXL P30530 1/20 0.36
FLT3 P36888 1/20 0.36
MERTK Q12866 1/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27407041 0.85 ABCG2 (0.38) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL11108383 0.76 EGFR (0.45) ALDH1A1HTT
SCHEMBL17120715 0.73 ESR2 (0.59) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL5584219 0.71 CHRM5 (0.38) ALDH1A1CYP1A2CYP3A4HPGDHTT
SCHEMBL9854331 0.69 CYP1A2 (0.52) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL7447420 0.69 AXL (0.42) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL4359377 0.68 ESR2 (0.66) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL31410710 0.67 ESR2 (0.76) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL4949949 0.67 ESR2 (0.51) ALDH1A1CYP1A2CYP3A4HSD17B10ESR2
SCHEMBL16484546 0.67 ESR2 (0.59) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0426021-A1 Condensed imidazole derivatives and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-05-08 EP disclosed